Long term study to evaluate the safety and benefit of subcutaneous RoActemra/Actemra in the treatment of Juvenile Idiopathic Arthritis patients

Update Il y a 4 ans
Reference: EUCTR2013-005212-98

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the long-term safety of subcutaneous (SC) administration of TCZ in patients with pcJIA and sJIA To describe the long-term efficacy of SC TCZ in patients with pcJIA and sJIA


Inclusion criteria

  • Polyarticular-course juvenile idiopathic arthritis (pJIA); Systemic juvenile idiopathic arthritis (sJIA)